lateral-epicondylitis-tennis-elbow-market

Lateral Epicondylitis (Tennis Elbow) Market By Treatment Type (Painkillers And Nsaids, Corticosteroid Injections , Shock Wave Therapy, Surgery, Equipment And Other Products) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

25 May 2016 Format PDF icon PPT icon XLS icon Request Sample

Growing prevalence of sports injuries, and elbow tendon bumps, joint pain are the key factors that have urged the advent of tennis elbow market. In the next few years the demand for tennis elbow treatment is expected to increase significantly in the emerging economies such as China and Canada. Geriatric population is growing with the rising global population, and rising sports events are leading to increase in number of sports injuries and these are expected to boost the industry in the coming years.

The treatments studies for analyzing the overall lateral epicondylitis market are painkillers and NSAIDs, corticosteroid injections shock wave therapy surgery, and equipment and other products. Market size and forecast for each of these segments for the period 2014-2023 are provided in this study along with respective CAGRs for the forecast period 2016-2023. This report also highlights information about major clinical trial candidates under scrutiny for lateral epicondylitis treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II and phase III.

Market size and forecast for these regional and country level markets are presented in this study for the period 2014-2023. Market growth rates for the forecast period 2016-2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global lateral epicondylitis market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global lateral epicondylitis market. This report concludes with company profiles section that highlights major information about the key players engaged in lateral epicondylitis market.

Type of Treatment Segmentation Investigation

Tennis elbow is disorder caused due to swelling of the tendons which leads to the pain in the arm and elbow. Repetitive motion of the arms can lead to a strain in the muscles and tendons, this can further lead to the microscopic tear of the tissues. A number of symptoms faced in  daily life signals towards the lateral epicondylitis such as pain felt in doing the tasks such as lifting something, straightening the wrist or raising the hands, making grip etc. A large number of treatments are available for the conditions which include intake of Painkillers and NSAIDs, Corticosteroid injections, shock wave therapy, surgery and equipment and other products. In base year 2015, Corticosteroids injection and Painkillers & NSAIDs accounted for approximately 50% - 55% of the total market share because these are the first line therapies preferred by medical practitioners, cost effective and majorly used as supportive therapies, and most accessible source of treatment across the globe. In addition equipment and other products segment is the largest and most recommended supportive treatment against lateral epicondylitis (tennis elbow).  

For the purpose of this study, the global lateral epicondylitis (tennis elbow) treatment market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The geographical segmentation of the global market for lateral epicondylitis (tennis elbow) treatment market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In base year 2015, North America accounted for the largest market in the lateral epicondylitis (tennis elbow) treatment market due to rising number of sport competitions & events in U.S. along with the rising awareness among the patients are the key factors contributing towards the growth of lateral epicondylitis treatment market in this region. Tennis elbow is estimated to have a prevalence of 1.3% in the overall population in North America. The incidences mainly occur around the age of 40-50 years. Growing geriatric population in the North America region is also expected to strengthen the demand for lateral epicondylitis treatment in the region. According to market experts, lateral epicondylitis treatment has a significant impact on the growth of anti-inflammatory drugs. The various anti-inflammatory drugs (NSAIDS) include cortisone, ibuprofen and aspirin. The data suggests that these are one of the widely used class of drugs, with approx. 70 million subscriptions and more than 30 billion over the counter tablets that are annually being sold in the U.S. These drugs are mainly used to control the pain of lateral epicondylitis.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Lateral Epicondylitis (Tennis Elbow) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Lateral Epicondylitis (Tennis Elbow) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Treatment type
  • Painkillers and NSAIDs
  • Corticosteroid injections
  • Shock wave therapy
  • Surgery
  • Equipment and other products

Pipeline treatments assessment
  • Phase I
  • Phase II
  • Phase III

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Lateral Epicondylitis (Tennis Elbow) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Lateral Epicondylitis (Tennis Elbow) market?
  • Which is the largest regional market for Lateral Epicondylitis (Tennis Elbow) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Lateral Epicondylitis (Tennis Elbow) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Lateral Epicondylitis (Tennis Elbow) market worldwide?
Choose Licence Type
$4325
$6325
$8325
Why Acute
View Other Reports